Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Asvadi P, Cuddihy A, Dunn RD, Jiang V, Wong MX, Jones DR, Khong T, Spencer A

(2015), Br J Haematol, 169(3), 333-43

ADAMs control inflammation from afar

Andrews RK, Gardiner EE

(2015), J Leukoc Biol, 97(3), 437-8

Modifying chemotherapeutic management of a patient with Burkitt’s lymphoma and pre-existing motor neurone disease

Bortz H, Coutsouvelis J, Corallo CE, Spencer A, Patil S

(2015), J Clin Pharm Ther, 40(4), 483-5

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB

(2015), Haematologica, 100(7), 914-26

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling VY, Lee D, McQuilten Z, Avery S, Low M, Cody SH, Nguyen T, McLean C, Gorniak M, Wei A, Ting SB

(2015), Am J Hematol, 90(12), E219-20

Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants

Cohen A, Jeyaindran S, Kim JY, Park K, Sompradeekul S, Tambunan KL, Tran H, Tsai IC, Ward C, Wong R

(2015), Thromb Res, 136(2), 196-207

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A

(2015), Br J Haematol, 169(2), 199-210

Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome

Qiao J, Davis AK, Morel-Kopp MC, Ward CM, Gardiner EE, Andrews RK

(2015), Ann Hematol, 94(12), 2069-71

Traumatic brain injury opens blood-brain barrier to stealth liposomes via an enhanced permeability and retention (EPR)-like effect

Boyd BJ, Galle A, Daglas M, Rosenfeld JV, Medcalf R

(2015), J Drug Target, 23(9), 847-53

Extracorporeal membrane oxygenation-hemostatic complications

Murphy DA, Hockings LE, Andrews RK, Aubron C, Gardiner EE, Pellegrino VA, Davis AK

(2015), Transfus Med Rev, 29(2), 90-101

Activation of the erythroid K-Cl cotransporter Kcc1 enhances sickle cell disease pathology in a humanized mouse model

Brown FC, Conway AJ, Cerruti L, Collinge JE, McLean C, Wiley JS, Kile BT, Jane SM, Curtis DJ

(2015), Blood, 126(26), 2863-70

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML

Rijal S, Fleming S, Cummings N, Rynkiewicz NK, Ooms LM, Nguyen NY, Teh TC, Avery S, McManus JF, Papenfuss AT, McLean C, Guthridge MA, Mitchell CA, Wei AH

(2015), Blood, 125(18), 2815-24

Approval of the first protease-activated receptor antagonist: rationale, development, significance, and considerations of a novel anti-platelet agent

French SL, Arthur JF, Tran HA, Hamilton JR

(2015), Blood Rev, 29(3), 179-89

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

Seymour JF, Pfreundschuh M, Trnĕný M, Sehn LH, Catalano J, Csinady E, Moore N, Coiffier B; MAIN Study Investigators

(2014), Haematologica, 99(8), 1343-9

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

Mesa RA, Kiladjian JJ, Verstovsek S, Al-Ali HK, Gotlib J, Gisslinger H, Levy R, Siulnik A, Gupta V, Khan M, DiPersio JF, McQuitty M, Catalano JV, Hunter DS, Knoops L, Deininger M, Cervantes F, Miller C, Vannucchi AM, Silver RT, Barbui T, Talpaz M, Barosi

(2014), Haematologica, 99(2), 292-8

Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period

Macesic N, Morrissey CO, Cheng AC, Spencer A, Peleg AY

(2014), Transpl Infect Dis, 16(6), 887-96

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

Cheah CY, Herbert KE, O'Rourke K, Kennedy GA, George A, Fedele PL, Gilbertson M, Tan SY, Ritchie DS, Opat SS, Prince HM, Dickinson M, Burbury K, Wolf M, Januszewicz EH, Tam CS, Westerman DA, Carney DA, Harrison SJ, Seymour JF

(2014), Br J Cancer, 111(6), 1072-9

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

Benboubker L, Dimopoulos MA, Dispenzieri A, Catalano J, Belch AR, Cavo M, Pinto A, Weisel K, Ludwig H, Bahlis N, Banos A, Tiab M, Delforge M, Cavenagh J, Geraldes C, Lee JJ, Chen C, Oriol A, de la Rubia J, Qiu L, White DJ, Binder D, Anderson K, Fermand JP

(2014), N Engl J Med, 371(10), 906-17

Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014

Morrissey CO, Gilroy NM, Macesic N, Walker P, Ananda-Rajah M, May M, Heath CH, Grigg A, Bardy PG, Kwan J, Kirsa SW, Slavin M, Gottlieb T, Chen S

(2014), Intern Med J, 44(12b), 1298-314

The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice

Lancaster GI, Kraakman MJ, Kammoun HL, Langley KG, Estevez E, Banerjee A, Grumont RJ, Febbraio MA, Gerondakis S

(2014), PLoS One, 9(11), e111524

23 24 25 26 27